+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Off-label prescribing in palliative care - a cross-sectional national survey of palliative medicine doctors

Off-label prescribing in palliative care - a cross-sectional national survey of palliative medicine doctors

Palliative Medicine 27(4): 320-328

Regulatory bodies including the European Medicines Agency register medications (formulation, route of administration) for specific clinical indications. Once registered, prescription is at clinicians' discretion. Off-label use is beyond the registered use. While off-label prescribing may, at times, be appropriate, efficacy and toxicity data are often lacking. The aim of this study was to document off-label use policies (including disclosure and consent) in Australian palliative care units and current practices by palliative care clinicians. A national, cross-sectional survey was conducted online following an invitation letter. The survey asked clinicians their most frequent off-label medication/indication dyads and unit policies. Dyads were classified into unregistered, off-label and on-label, and for the latter, whether medications were nationally subsidised. All Australian palliative medicine Fellows and advanced trainees. Overall, 105 clinicians responded (53% response rate). The majority did not have policies on off-label medications, and documented consent rarely. In all, 236 medication/indication dyads for 36 medications were noted: 45 dyads (19%) were for two unregistered medications, 118 dyads (50%) were for 26 off-label medications and 73 dyads (31%) were for 12 on-label medications. Off-label prescribing with its clinical, legal and ethical implications is common yet poorly recognised by clinicians. A distinction needs to be made between where quality evidence exists but registration has not been updated by the pharmaceutical sponsor and the evidence has not been generated. Further research is required to quantify any iatrogenic harm from off-label prescribing in palliative care.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 036726380

Download citation: RISBibTeXText

PMID: 23128901

DOI: 10.1177/0269216312464263

Related references

Prescribing for nausea in palliative care: a cross-sectional national survey of Australian palliative medicine doctors. Journal of Palliative Medicine 17(9): 1032-1036, 2015

Palliative and end-of-life care education in Canadian emergency medicine residency programs: A national cross-sectional survey. Cjem 2019: 1-7, 2019

Mapping the scope of occupational therapy practice in palliative care: A European Association for Palliative Care cross-sectional survey. Palliative Medicine 32(5): 960-968, 2018

"Please describe from your point of view a typical case of an error in palliative care": Qualitative data from an exploratory cross-sectional survey study among palliative care professionals. Journal of Palliative Medicine 17(3): 331-337, 2014

Possible associations between palliative care conferences and positive outcomes when performing palliative care for patients with end-stage heart failure: a nationwide cross-sectional questionnaire survey. Heart and Vessels 2018, 2018

Attitudes to specialist palliative care and advance care planning in people with COPD: a multi-national survey of palliative and respiratory medicine specialists. Bmc Palliative Care 17(1): 115, 2018

Pediatric palliative care programs in children's hospitals: a cross-sectional national survey. Pediatrics 132(6): 1063-1070, 2014

Examining self-care, self-compassion and compassion for others: a cross-sectional survey of palliative care nurses and doctors. International Journal of Palliative Nursing 24(1): 4-11, 2018

Circumstances of hospital admissions in palliative care: A cross-sectional survey of patients admitted to hospital with palliative care needs. Palliative Medicine 32(5): 1030-1036, 2018

Off-label prescribing in palliative care: a survey of independent prescribers. Palliative Medicine 27(4): 314-319, 2013

Pain and pain treatments in European palliative care units. A cross sectional survey from the European Association for Palliative Care Research Network. Palliative Medicine 19(6): 477-484, 2005

What, how and from whom do health care professionals learn during collaboration in palliative home care: a cross-sectional study in primary palliative care. Bmc Health Services Research 14: 501, 2016

Effectiveness of the Certificate Course in Essentials of Palliative Care Program on the Knowledge in Palliative Care among the Participants: A Cross-sectional Interventional Study. Indian Journal of Palliative Care 24(1): 86-92, 2018

Exploring the interface between 'physician-assisted death' and palliative care: cross-sectional data from Australasian palliative care specialists. Internal Medicine Journal 46(4): 443-451, 2017

US survey finds higher availability of palliative care programs, palliative physicians and consultation teams and palliative outpatient services in National Cancer Institute centres compared to non-NCI centres. Evidence-Based Nursing 13(4): 105-106, 2010